For example, auranofin, an FDA-approved gold(I) complex for treating rheumatoid arthritis, has attracted attention over the past decade for its cancer-inhibiting properties by directly targeting TrxR1 (Momose et al., 2021). Here, TXNRD1 is linked to cancer.